UNSPSC 51285304: Nifurtoinol

This classification denotes a urinary anti-infective agent with the molecular formula C9H8N4O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 980688H13O, chemically known as 2,4-imidazolidinedione, 3-(hydroxymethyl)-1-(((5-nitro-2-furanyl)methylene)amino)- but more generally known as nifurtoinol, which bears US NIH Compound Identifier 9571062. European Medicines Agency schedules Nifurtoinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09281MIG.

UNSPSC 51285304 Nifurtoinol, a Commodity code, does not align with actual state and local procurement activity in the recent opportunities record. The source contains four recent solicitations—from Seminole County, Florida (naloxone and drug deactivation systems); Texas Health and Human Services Commission (direct-to-manufacturer prescription programs); City of Tampa (medical and first aid supplies for fire rescue); and Minnesota Multistate Cooperative Purchasing Alliance (generic pharmaceuticals and OTC products)—none of which reference nifurtoinol or match the pharmaceutical scope implied by the code name. The opportunities instead reflect procurement of naloxone, emergency medical supplies, generic pharmaceuticals, and pharmacy benefit program administration across state health agencies, counties, cities, and cooperative purchasing consortia. The mismatch suggests either a data-entry error in code assignment or that nifurtoinol purchases, if they occur at state and local level, do not appear in current market activity.

The issuing bodies span state health and human services departments (Texas HHS, Minnesota Department of Administration), county health agencies (Seminole County), municipal fire departments (City of Tampa), and multi-state cooperative purchasing vehicles (MMCAP). Geographic activity centers on Florida, Texas, and Minnesota, with MMCAP covering multiple states including Oregon. Representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 drug deactivation systems annually (due Jul 26, 2023); City of Tampa's IFB for 169 line items of medical and first aid supplies totaling an estimated $700,000 with SLBE set-aside (due Mar 13, 2026); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with proposals due Mar 26, 2026. The code shows little relevant recent activity specific to nifurtoinol procurement.